96 related articles for article (PubMed ID: 12063949)
21. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of p16INK4 is a reliable marker of human papillomavirus-induced oral high-grade squamous dysplasia.
Cunningham LL; Pagano GM; Li M; Tandon R; Holm SW; White DK; Lele SM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul; 102(1):77-81. PubMed ID: 16831676
[TBL] [Abstract][Full Text] [Related]
23. Clinical and endoscopic presentation of primary gastric lymphoma: a multicentre study.
Andriani A; Zullo A; Di Raimondo F; Patti C; Tedeschi L; Recine U; Caruso L; Bonanno G; Chiarenza A; Lizzani G; Miedico A; Romanelli A; Costa A; Linea C; Marrone C; Mirto S; Mistretta A; Montalbano L; Restivo G; Vinci M; Bibas M; Hassan C; Stella F; Cottone M; Morini S
Aliment Pharmacol Ther; 2006 Mar; 23(6):721-6. PubMed ID: 16556173
[TBL] [Abstract][Full Text] [Related]
24. Tissue microarray analysis of multiple gene expression in intestinal metaplasia, dysplasia and carcinoma of the stomach.
Sun Y; Li JY; He JS; Zhou LX; Chen K
Histopathology; 2005 May; 46(5):505-14. PubMed ID: 15842632
[TBL] [Abstract][Full Text] [Related]
25. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
26. The immunohistochemical expression of E-cadherin in gastric cancer; correlations with clinicopathological factors and patients' survival.
Lazăr D; Tăban S; Ardeleanu C; Dema A; Sporea I; Cornianu M; Lazăr E; Vernic C
Rom J Morphol Embryol; 2008; 49(4):459-67. PubMed ID: 19050793
[TBL] [Abstract][Full Text] [Related]
27. CD44v6: a potential marker of malignant transformation in intestinal metaplasia of the stomach? An immunohistochemical study using tissue microarrays.
Gulmann C; Grace A; Leader M; Butler D; Patchett S; Kay E
Eur J Gastroenterol Hepatol; 2003 Sep; 15(9):981-6. PubMed ID: 12923370
[TBL] [Abstract][Full Text] [Related]
28. Immunophenotype of sporadic and familial adenomatous polyposis associated fundic gland polyps: a mucin and MIB1 study.
Declich P; Carneiro F; Omazzi B; Tavani E; Grassini R; Ferrara A; Bortoli A; Bellone S; Gozzini C; Prada A
Pol J Pathol; 2006; 57(3):141-8. PubMed ID: 17219741
[TBL] [Abstract][Full Text] [Related]
29. [Role of polymorphism of certain cytokines in gastric cancer in Mexico. Preliminary results].
Garza-González E; Hold G; Pérez-Pérez GI; Bosques-Padilla FJ; Tijerina-Menchaca R; Maldonado-Garza HJ; el-Omar E
Rev Gastroenterol Mex; 2003; 68(2):107-12. PubMed ID: 15127646
[TBL] [Abstract][Full Text] [Related]
30. Cytomorphologic spectrum of small lymphocytic lymphoma in patients with an accelerated clinical course.
Shin HJ; Caraway NP; Katz RL
Cancer; 2003 Oct; 99(5):293-300. PubMed ID: 14579296
[TBL] [Abstract][Full Text] [Related]
31. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
32. The risk of dysplasia and cancer in the ileal pouch mucosa after restorative proctocolectomy for ulcerative proctocolitis is low: a long-term term follow-up study.
Börjesson L; Willén R; Haboubi N; Duff SE; Hultén L
Colorectal Dis; 2004 Nov; 6(6):494-8. PubMed ID: 15521942
[TBL] [Abstract][Full Text] [Related]
33. Combined alpha-methylacyl coenzyme A racemase/p53 analysis to identify dysplasia in inflammatory bowel disease.
Marx A; Wandrey T; Simon P; Wewer A; Grob T; Reichelt U; Minner S; Simon R; Spehlmann M; Tigges W; Soehendra N; Seitz U; Seewald S; Izbicki JR; Yekebas E; Kaifi JT; Mirlacher M; Terracciano L; Fleischmann A; Raedler A; Sauter G
Hum Pathol; 2009 Feb; 40(2):166-73. PubMed ID: 18835622
[TBL] [Abstract][Full Text] [Related]
34. [Characteristic of inflammatory infiltrate of gastric mucosa in patients with grade II-III gastric dysplasia and of stomach cancer].
Evtushenko VA; Vusik MV; Karakeshisheva MB; Pleshko RI; Ermolaeva LA
Klin Med (Mosk); 2008; 86(11):48-53. PubMed ID: 19177795
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical expression of vascular endothelial growth factor (VEGF) in intestinal type gastric carcinoma.
Raica M; Mogoantă L; Cîmpean AM; Alexa A; Ioanovici S; Mărgăritescu C; Lazăr D; Izvernariu D
Rom J Morphol Embryol; 2008; 49(1):37-42. PubMed ID: 18273500
[TBL] [Abstract][Full Text] [Related]
36. Bax and Bcl-2 protein expression in gastric precancerous lesions: immunohistochemical study.
Anagnostopoulos GK; Stefanou D; Arkoumani E; Sakorafas G; Pavlakis G; Arvanitidis D; Tsianos E; Agnantis NJ
J Gastroenterol Hepatol; 2005 Nov; 20(11):1674-8. PubMed ID: 16246184
[TBL] [Abstract][Full Text] [Related]
37. Helicobacter pylori infection affects the expression of PCNA, p53, c-erbB-2 and Bcl-2 in the human gastric mucosa.
Jorge O; Cuello Carrión FD; Jorge A; Ciocca DR
Rev Esp Enferm Dig; 2003 Feb; 95(2):97-104, 89-96. PubMed ID: 12760717
[TBL] [Abstract][Full Text] [Related]
38. Extent of low-grade dysplasia in Barrett's esophagus: is it useful for risk stratification?
Falk GW; Goldblum JR
Am J Gastroenterol; 2007 Mar; 102(3):494-6. PubMed ID: 17335444
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical expression of the cyclooxygenase-2 (COX-2) in gastric cancer. The correlations with the tumor angiogenesis and patients' survival.
Lazăr D; Tăban S; Ardeleanu C; Simionescu C; Sporea I; Cornianu M; Vernic C
Rom J Morphol Embryol; 2008; 49(3):371-9. PubMed ID: 18758643
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
